Population screening requires robust evidence—genomics is no exception

This publication has 14 references indexed in Scilit:

• Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts
  The American Journal of Human Genetics, 2022
• Parental Attitudes Toward Standard Newborn Screening and Newborn Genomic Sequencing: Findings From the BabySeq Study
  Frontiers in Genetics, 2022
• Prostate cancer polygenic risk score and prediction of lethal prostate cancer
  npj Precision Oncology, 2022
• The role of exome sequencing in newborn screening for inborn errors of metabolism
  Nature Medicine, 2020
• The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
  Genetics in Medicine, 2019
• Overdiagnosis: what it is and what it isn’t
  BMJ Evidence-Based Medicine, 2018
• Familial Risk and Heritability of Cancer Among Twins in Nordic Countries
  JAMA, 2016
• Variability in gene expression underlies incomplete penetrance
  Nature, 2010
• Maximising benefit and minimising harm of screening
  BMJ, 2008
• Heritability of death from coronary heart disease: a 36‐year follow‐up of 20 966 Swedish twins
  Journal of Internal Medicine, 2002